Flavopiridol Protects Against Inflammation by Attenuating Leukocyte-Endothelial Interaction via Inhibition of Cyclin-Dependent Kinase 9
暂无分享,去创建一个
S. Zahler | F. Totzke | A. Vollmar | J. Joore | G. Tiegs | F. Krombach | A. Khandoga | R. Fürst | G. Sass | Bettina A. Mayer | Nina Berberich | Ulrike K Schmerwitz
[1] Z. Obradovic,et al. Selective control of gene expression by CDK9 in human cells , 2010, Journal of cellular physiology.
[2] C. Haslett,et al. Cyclin‐dependent kinase inhibitor drugs as potential novel anti‐inflammatory and pro‐resolution agents , 2009, British journal of pharmacology.
[3] S. Zahler,et al. Investigation of the marine compound spongistatin 1 links the inhibition of PKCα translocation to nonmitotic effects of tubulin antagonism in angiogenesis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] P. Kubes,et al. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids , 2008, The Journal of experimental medicine.
[5] S. Choudhary,et al. RelA Ser276 Phosphorylation Is Required for Activation of a Subset of NF-κB-Dependent Genes by Recruiting Cyclin-Dependent Kinase 9/Cyclin T1 Complexes , 2008, Molecular and Cellular Biology.
[6] Takahiko Sugihara,et al. Successful Treatment of Animal Models of Rheumatoid Arthritis with Small-Molecule Cyclin-Dependent Kinase Inhibitors1 , 2008, The Journal of Immunology.
[7] A. Brasier,et al. The Functional Role of an Interleukin 6-inducible CDK9·STAT3 Complex in Human γ-Fibrinogen Gene Expression* , 2007, Journal of Biological Chemistry.
[8] L. Meijer,et al. Inverse in silico screening for identification of kinase inhibitor targets. , 2007, Chemistry & biology.
[9] G. Remuzzi,et al. Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus. , 2007, Arthritis and rheumatism.
[10] S. Zahler,et al. MAPK phosphatase‐1 represents a novel anti‐inflammatory target of glucocorticoids in the human endothelium , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] Christopher Haslett,et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis , 2006, Nature Medicine.
[12] S. Zahler,et al. Atrial Natriuretic Peptide Induces Mitogen-Activated Protein Kinase Phosphatase-1 in Human Endothelial Cells via Rac1 and NAD(P)H Oxidase/Nox2-Activation , 2004, Circulation research.
[13] B. Aggarwal,et al. Flavopiridol Inhibits NF-κB Activation Induced by Various Carcinogens and Inflammatory Agents through Inhibition of IκBα Kinase and p65 Phosphorylation , 2004, Journal of Biological Chemistry.
[14] W. Kuebler,et al. Visualization of Leukocyte Transendothelial and Interstitial Migration Using Reflected Light Oblique Transillumination in Intravital Video Microscopy , 2003, Journal of Vascular Research.
[15] H. Handa,et al. Suppression of NF‐κB‐dependent gene expression by a hexamethylene bisacetamide‐inducible protein HEXIM1 in human vascular smooth muscle cells , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[16] A. Giordano,et al. Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines , 2002, Oncogene.
[17] Andreas Rosenwald,et al. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol , 2001, Genome Biology.
[18] D. Price,et al. Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo * , 2001, The Journal of Biological Chemistry.
[19] B. Peterlin,et al. NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II , 2001 .
[20] E. Sausville,et al. Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. , 1996, International journal of oncology.
[21] R. Swerlick,et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.
[22] A. Wendel,et al. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.
[23] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[24] Mindy I. Davis,et al. A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.